Haematology and Plasma Cell Disorders
Landspitali supports clinical research in multiple myeloma and smoldering multiple myeloma, with attention to both intermediate-risk and high-risk disease. Its research activity includes evaluation of treatment strategies aimed at disease control and deeper response in patients with plasma cell malignancies.
- Multiple myeloma
- Smoldering multiple myeloma
- Minimal residual disease assessment
These studies reflect a focus on blood cancer management within a hospital-based clinical research setting in Iceland.
Gastroenterology and Upper Digestive Symptoms
The sponsor also funds research in dyspepsia, examining symptom improvement and treatment duration in patients with unexplained upper gastrointestinal discomfort. This area centers on common digestive symptoms and their response to acid-suppressive therapy.
- Dyspepsia
- Upper gastrointestinal symptoms
- Proton pump inhibitor therapy
The clinical interest lies in symptom burden, treatment response, and practical care for patients seen in routine hospital practice.
